Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Journal of the National Cancer Institute
|
June 14, 2014
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147
Wilson I Gonsalves, Michelle R Mahoney, Daniel J Sargent, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention
Paul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
JAMA
|
April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
Steven R Alberts, Daniel J Sargent, Suresh Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Clinical Trials (London, England)
|
December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Clinical Colorectal Cancer
|
February 12, 2014
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147
Jocelin Huang, Suresh G Nair, Michelle R Mahoney, et al.
The New England Journal of Medicine
|
December 22, 2018
Sorafenib for Advanced and Refractory Desmoid Tumors
Mrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Journal of the National Cancer Institute
|
June 14, 2014
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147
Wilson I Gonsalves, Michelle R Mahoney, Daniel J Sargent, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention
Paul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
JAMA
|
April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
Steven R Alberts, Daniel J Sargent, Suresh Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Clinical Trials (London, England)
|
December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Clinical Colorectal Cancer
|
February 12, 2014
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147
Jocelin Huang, Suresh G Nair, Michelle R Mahoney, et al.
The New England Journal of Medicine
|
December 22, 2018
Sorafenib for Advanced and Refractory Desmoid Tumors
Mrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, et al.
Page
of 5